Side Effect clinical trials

Explore recruiting side effect clinical trials.

Recruiting side effect studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Side Effect trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

sElective Serotonin reuPtake inhibitoRs In posT-covid: ESPRIT

Netherlands

Phase III and phase IV (Integrated) EU CTIS Study details

(LAX) A Randomized, open label, Non-inferiority trial on the efficacy of Lacosamide versus Duloxetine in Patients with Chemotherapy-induced Polyneuropathy - A strategy trial

Netherlands

Therapeutic use (Phase IV) EU CTIS Study details

A Phase 2, open-label, multicenter study to evaluate efficacy and safety of zanidatamab for the treatment of participants with previously treated HER2-expressing solid tumors (DiscovHER PAN-206)

Spain

Therapeutic exploratory (Phase II) EU CTIS Study details

Phase 1/2 Trial to determine the safety and efficacy of Extracorporeal photopheresis as treatment for steriod-refractory immune related adverse events after immune checkpoint inhibitor therapy - ECIR

Germany

Phase I and Phase II (Integrated)- Other EU CTIS Study details

Patient-Centered Study of Trastuzumab Deruxtecan (T-DXd) in First-Line HER2-POsitive Metastatic Breast Cancer with Proactive Toxicity ManagementReflecting Real-World Clinical Practice / TOP-REAL Trial

France, Germany, Spain

Therapeutic confirmatory (Phase III) EU CTIS Study details

Preventing oxidative stress-induced ischemic injury and systemic inflammation complications during and after invasive cardiac surgery with alkaline phosphatase (APPIRED III)

Belgium, Austria

Therapeutic confirmatory (Phase III) EU CTIS Study details

Side Effect trials by city

Side Effect in Toronto Side Effect in Vancouver Side Effect in Montreal Side Effect in Calgary Side Effect in Edmonton Side Effect in Ottawa Side Effect in Winnipeg Side Effect in Quebec City Side Effect in Hamilton Side Effect in Kitchener Side Effect in London Side Effect in Halifax Side Effect in New York Side Effect in Los Angeles Side Effect in Chicago Side Effect in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease